Filing Flows › Arcadia Biosciences (RKDA) › Q1 2025
Arcadia Biosciences (RKDA) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
Arcadia Biosciences (RKDA) reported revenue of $1.2M for the first quarter 2025 (Q1 2025), +22% from a year earlier and -1% from the quarter before. Operating margin was 44.2%, net earnings $2.6M (216.6% of revenue).
Arcadia Biosciences, Q1 2025: revenue $1.2M (+22% year over year), operating margin 44.2%, net earnings $2.6M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.2M | -1% | +22% |
| Operating profit | $530K | — | — |
| Net earnings | $2.6M | — | — |
| Operating cash flow | −$1.6M | — | — |
What changed
Revenue was $1.2M in Q1 2025, up 22% year over year and down 1% from the previous quarter.
Operating profit was $530K, a 44.2% margin (up 205.1 points year over year). Total costs fell 74% while revenue rose 22%. Net earnings were $2.6M. The effective tax rate was 0.0%. Non-operating items added $2.1M, 80% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.6M. Non-cash charges added back $13K of depreciation and $78K of share-based compensation. Working capital and other items used $4.3M.
Questions
What was Arcadia Biosciences' revenue in the first quarter 2025?
Arcadia Biosciences (RKDA) reported revenue of $1.2M for the first quarter 2025 (Q1 2025), +22% from a year earlier and -1% from the quarter before.
Was Arcadia Biosciences profitable in the first quarter 2025?
Operating profit was $530K (44.2% of revenue) and net earnings $2.6M.